The Immuno-Oncology & Biomarker Summit 2026 brings together global experts in oncology research, translational science, and clinical development to accelerate next-generation immunotherapies. The program covers biomarker discovery, predictive diagnostics, companion diagnostics, AI-driven analytics, multi-omic integration, regulatory science, trial design, and real-world evidence strategies. With participation from biopharma leaders, clinicians, diagnostic developers, data scientists, and regulators, the summit facilitates high-impact knowledge exchange and collaboration to advance precision oncology. Through keynote talks, panel discussions, case studies, and dedicated networking, the event aims to reduce clinical attrition and accelerate the delivery of innovative IO therapies to patients worldwide.
Date: 16–17 March 2026 | Millennium Hotel and Conference Centre Gloucester London